Publicacións en colaboración con investigadores/as de Hospital Xàtiva Lluis Alcanyis (18)

2024

  1. Surgery for inflammatory bowel disease in Spain: How are we doing? Initial results of a nationwide prospective registry

    Cirugia Espanola, Vol. 102, Núm. 7, pp. 355-363

2022

  1. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

  2. Prediction of peritoneal soiling in acute appendicitis with simple clinical and laboratory data. Prospective, multicenter, cohort study of 2,645 adult patients nationwide

    International Journal of Surgery, Vol. 104

  3. Simplified risk-prediction for benchmarking and quality improvement in emergency general surgery. Prospective, multicenter, observational cohort study

    International Journal of Surgery, Vol. 97

2021

  1. Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2

    International Journal of Cardiology, Vol. 330, pp. 268-272

  2. Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

  3. Parestomal hernia repair. Prospective observational study based on the Spanish Registry of Incisional Hernia (EVEREG)

    Cirugia Espanola, Vol. 99, Núm. 7, pp. 527-534

2020

  1. Predictors of response to exclusive enteral nutrition in newly diagnosed crohn’s disease in children: PRESENCE Study from SEGHNP

    Nutrients, Vol. 12, Núm. 4

2017

  1. EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure

    Acta Neurologica Scandinavica, Vol. 136, Núm. 3, pp. 254-264

  2. Erratum to “Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study” [Epilepsy Res. (2016) 126 (201–210)] (S0920121116301218)(10.1016/j.eplepsyres.2016.08.001)

    Epilepsy Research

2016

  1. Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study

    Epilepsy Research, Vol. 126, pp. 201-210

2015

  1. Early Add-on Lacosamide in a Real-Life Setting: Results of the REALLY Study

    Clinical Drug Investigation, Vol. 35, Núm. 2, pp. 121-131

2009

  1. Incidence of adult form of autoimmune hepatitis in Valencia (Spain)

    Acta Gastro-Enterologica Belgica, Vol. 72, Núm. 4, pp. 402-406

2008

  1. Estudio clínico de la hepatitis autoinmune del adulto en Valencia

    Revista Espanola de Enfermedades Digestivas, Vol. 100, Núm. 7, pp. 400-404

2007

  1. New insights into the circadian rhythm of acute myocardial infarction in subgroups

    Chronobiology International, Vol. 24, Núm. 1, pp. 129-141

2006

  1. Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: A cross-sectional study

    Cardiovascular Diabetology, Vol. 5

2005

  1. Control of hypertension in patients at high risk of cardiovascular disease

    QJM - Monthly Journal of the Association of Physicians, Vol. 98, Núm. 8, pp. 581-588

2001

  1. Risk and prognostic factors of Pseudomonas aeruginosa bacteremia in critically ill patients

    Medicina Clinica, Vol. 117, Núm. 19, pp. 721-726